HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedNCT01156051

Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

This study has public registry information. It focuses on ADHD and currently lists study information in the United States.

ADHD, Attention Deficit Disorder, ...DrugFrom 6 Years to 12 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 12 years.

Listed locations
Hamilton, United States · Toms River, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJune 2010
Recruitment status
Terminated
Enrollment listed in the registry
29
Sponsor
Children's Specialized Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT01156051
Official title
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01156051. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Terminated

Hamilton · Toms River

Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Children's Specialized Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Guanfacine extended-release tablets and Placebo comparator.

Who can participate?

Listed age limits: 6 years to 12 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.